One of Pfizer Pharmaceutical's general corporate goals is that no person anywhere should be restricted from receiving essential and affordable medicines. From 2009 to 11 Pfizer's internal corporate social responsibility (csr) programmes were private corporate efforts that were discretionary and limited in scope and impact. All Pfizer's csr preferred public policy governmental positions encompassed neoliberal government requirements based on market and profit considerations, with no positions demonstrating, in detail, how universal provision of drugs for all would be provided. Currently Pfizer's csr efforts represent a dichotomy when compared with the general corporate goal of not restricting essential and affordable medicines in order to provide medicines for all.
